van de Ven, Michiel
IJzerman, Maarten
Retèl, Valesca
van Harten, Wim
Koffijberg, Hendrik https://orcid.org/0000-0002-1753-0652
Article History
Received: 6 August 2021
Accepted: 10 March 2022
First Online: 27 March 2022
Declarations
:
: The need for ethics approval is waived, as the study does not concern medical scientific research and does not include human subjects [].
: Not applicable.
: Dr. van Harten and Dr. Retèl have both received non-restricted research grants from Agendia B.V. and Novartis. Dr. IJzerman received a non-restricted research grant from Illumina. All other authors have no conflicts of interest to disclose.